Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

571 articles

Research Review

Showing 1–1 of 1 articles · Keyword: Primary graft dysfunction (PGD) Clear keyword

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Cell and Gene Therapy in Lung Transplantation: From Experimental Promise towards Clinical Translation

Olm F, Kortleven P, Mittendorfer M, Carlon Ms, Ceulemans Lj, Lindstedt S

Lung transplantation (LTx) remains the only definitive therapy for selected patients with end-stage lung disease, yet outcomes are limited by early ischemia-reperfusion injury (IRI) and primary graft dysfunction (PGD), and by chronic lung allograft dysfunction (CLAD) as the leading cause of late graft failure.

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.